2 days Abbott Laboratories’ (ABT) Buy Rating Reaffirmed at Raymond JamesMarketBeat
Raymond James reissued a “buy” rating and set a $129.00 target price (up previously from $122.00) on shares of Abbott Laboratories in a report on Monday.
XRaymond James reissued a “buy” rating and set a $129.00 target price (up previously from $122.00) on shares of Abbott Laboratories in a report on Monday.
X